Oral contraceptives are now the most widely used form of contraception. In the U.S., the daily oral contraceptive pills have traditionally only been available with a prescription, but current legislative and advocacy efforts in some states have focused on broadening access to oral contraceptives by eliminating the requirement that women first have an in-person clinical visit. This factsheet provides an overview of oral contraception, discusses private insurance and Medicaid coverage, and reviews emerging strategies to promote and expand women’s access to oral contraceptives.
- view as grid
- view as list
This fact sheet examines the U.S. government’s role in family planning and reproductive health worldwide.
The U.S. Government and International Family Planning & Reproductive Health: Statutory Requirements and Policies
This fact sheet summarizes the major statutory requirements and policies pertaining to U.S. global family planning/reproductive health (FP/RH) efforts over time and identifies those currently in effect, including the Mexico City Policy and the Kemp-Kasten Amendment.
Modeling the Impact of Global Health Budget Cuts on HIV, TB, Family Planning, and Maternal, Newborn, and Child Health
President Trump’s fiscal year 2018 budget request would cut global health programs by approximately $2.5 billion. As Congress begins considering the Administration’s request, a new Kaiser Family Foundation analysis models the potential impact of the Administration’s proposed budget, as well as two budget scenarios with more modest decreases. Among the…
President Trump’s fiscal year 2018 budget request would cut global health programs by approximately $2.5 billion. This analysis models the potential impact of the Administration’s proposed budget, as well as two budget scenarios with more modest decreases.
This fact sheet provides an overview of the Mexico City Policy, which requires foreign non-governmental organizations (NGOs) to certify that they will not “perform or actively promote abortion as a method of family planning,” using funds from any source (including non-U.S. funds), as a condition for receiving U.S. government global family planning assistance and any other U.S. global health assistance.
This fact sheet provides an overview of the history of the Kemp-Kasten amendment, which states that no U.S. funds may be made available to “any organization or program which, as determined by the president of the United States, supports or participates in the management of a program of coercive abortion or involuntary sterilization,” and examines its current application. Since enacted in 1985, Kemp-Kasten has often been used to withhold funding from the United Nations Population Fund (UNFPA).
The American Health Care Act recently passed by the House of Representatives includes a provision to ban federal Medicaid funding of Planned Parenthood. The Trump administration has also proposed reducing funding to HHS, which funds the Title X family planning program and community health centers. A new brief from the…
This brief reviews the role Medicaid, the Title X Family Planning Program, and Section 330 of the Public Health Service Act in financing care and enabling access to family planning services and addresses the potential impact of actions taken by President Trump and Congress to block federal funds from Planned Parenthood and other entities that provide abortion.
In this brief, the Kaiser Family Foundation outlines 10 ways women could be affected under the House of Representatives’ American Health Care Act. In particular, the brief analyzes how changes might affect Medicaid and its expansion population, financial assistance in the individual insurance market, coverage for essential health benefits and preventive services such as contraception, abortion, and maternity care, as well as insurance reforms such as gender rating.